Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
about
Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under developmentNon-systemic drugs: a critical reviewStructural basis of the alternating-access mechanism in a bile acid transporterRole of the intestinal bile acid transporters in bile acid and drug dispositionExploitation of bile acid transport systems in prodrug design.Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2.Update on patented cholesterol absorption inhibitors.Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery.Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents.Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6).Toxic bile and sclerosing cholangitis: Is there a role for pharmacological interruption of the bile acid enterohepatic circulation?Persimmon fruit tannin-rich fiber reduces cholesterol levels in humans.Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.
P2860
Q26830274-7C2856B7-E60D-4D4D-ADE0-27CE71EE7433Q26863371-F786CE11-CBD0-4302-BD87-04A0290E39B9Q27680833-80F38DBB-D7B5-4AF1-B62F-D6BD24048120Q28299162-29DE74F9-D899-477E-A3D9-550398D4F84FQ36981149-B4FAE349-5BCB-4EE9-AB80-A59D8F985BB3Q37266253-5A3C3F20-2CA4-4946-BA5F-FC9069D011C0Q37529796-B66AF794-07D9-4C75-AC1C-0D3E397BE127Q37824864-A142DEED-A4F4-422C-A9DA-B17B8337162DQ38814420-278E104A-548E-40C5-93BC-5A2B41DB5604Q40134783-4939EBE3-85B6-4056-8F83-28C6EF7B8CB2Q42686933-51E5AE0B-4CD6-4A80-872B-97768F59AF6BQ44005762-83C9D8BE-F7DE-43BB-9ACB-C9FB1A4F54B0Q47399864-7D5FAEF2-D5E5-4582-AD39-1498355D764AQ51367888-F4AED531-8002-4AEA-B4CD-F3A79F6D9300
P2860
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
@ast
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
@en
type
label
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
@ast
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
@en
prefLabel
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
@ast
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
@en
P1476
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs.
@en
P2093
Heiner Glombik
Werner Kramer
P304
P356
10.2174/092986706776361003
P577
2006-01-01T00:00:00Z